Search Results for "Abbott Dartford Murex Biotech Ltd"

01:32 EST 28th January 2015 | BioPortfolio

Original Source: Murex Biotech Limited

Murex Biotech Ltd is part of the diagnostics division and is one of four Abbott sites within the UK. The company has steadily expanded to comprise a total UK workforce of over 2500 employees. At Murex, we are dedicated to the development and manufacture of products for the: detection monitoring screening of infectious diseases and other medical conditions. Murex is based at Dartford, Kent, and its principle focus is a range of enzyme immunoassay products for use by blood transfusion services throughout ...

Matching Channels

Abbott

The 11th largest pharmaceutical company in the world, Abbott Laboratories generated sales of $16 billion in 2009 and has 90,000 employees. Within the medical device arm of the company, products of...

Urokinase Abbott

Biotech jobs

The Top 10 Medical Device Companies

Medical devices are crucial to the process of diagnosis and treatment in modern medicine. Sales in this field reach billions of dollar a year, with Johnson & Johnson making $30 billion alone in ...

Czech Republic

Able to take advantage of a €2 European funding stimulus in 2009, the Czech Republic is one of Europe's top 5 centers for biotechnology companies. In just over decade, the Czech Republic ha...

Matching News

ABL and Abbott sign a biotech deal for HIV genotyping analysis

Advanced Biological Laboratories has granted Abbott non-exclusive rights to market ABL’s software suite for HIV genotyping data analysis. Abbott will utilize its expertise in infectious disease diag...

Abbott signs a biotech deal with US Defense Department

Abbott and the United States Department of Defense announced a collaboration with the intent to develop portable blood tests to help evaluate potential concussions, also called mild traumatic brain in...

Abbott Labs Begins Tender Offer For CFR Pharma

NORTH CHICAGO (dpa-AFX) - Diversified healthcare company Abbott Laboratories (ABT) said Monday that its wholly-owned subsidiary, Abbott Laboratories (Chile) Holdco (Dos) SpA, a Chilean corporation...

Abbott Acquires Veropharm for $305M

Abbott announced that it has acquired control of Veropharm, a leading Russian pharmaceutical manufacturer.Abbott has had a presence in Russia for nearly 40 years and, in line with its long-term commit...

Abbott Approves $3B Share Buyback

ABBOTT PARK, Ill. (AP) — Abbott Laboratories said Thursday that its board approved spending up to $3 billion to buy back the health conglomerate's stock.The company, which makes Similac infant formu...

Abbott Announces Increase in Quarterly Dividend

ABBOTT PARK, Ill., Dec. 12, 2014 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today increased the company's quarterly common dividend to $0.24 per share from $0.22 per share....

Abbott to Present at Credit Suisse 2014 Healthcare Conference

ABBOTT PARK, Ill., Nov. 4, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) will participate in the Credit Suisse 2014 Healthcare Conference on Tuesday, Nov. 11, 2014. Thomas C. Freyman, executive vice preside...

Mylan and Abbott: it's still on

"We remain on track to divest our developed markets business in Mylan in the first quarter of next year," said Abbott CEO Miles White this week when presenting Abbott's third quarter results. Also, Ab...

Matching PubMed Articles

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement